{"id":1292,"date":"2013-11-28T16:30:56","date_gmt":"2013-11-28T16:30:56","guid":{"rendered":"http:\/\/192.168.0.202\/en\/?p=1292"},"modified":"2015-09-11T09:07:00","modified_gmt":"2015-09-11T09:07:00","slug":"actavis-plc-act-analysis-and-outlook","status":"publish","type":"post","link":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/","title":{"rendered":"Actavis plc (ACT). Analysis and outlook"},"content":{"rendered":"<p>ABOUT ACT<br \/>\nActavis plc, an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical products in the United States, Canada, and internationally. It offers generic, branded, branded generic, biosimilar, over-the-counter, biologic, and specialty pharmaceutical products in various formulations, including modified release, solid oral dosage, semi-solids, liquids, gels, transdermal products, and injectables; and develops and out-licenses generic pharmaceutical products to customers through its third-party business.<\/p>\n<p>ACT Technical analysis<br \/>\nACT is trading in the range of $144.00 &#8211; $166.00 in the past 30 days. The stock has been showing support at $154.00 and resistance in the $165.00 range. The stock is trading above the 50-Day Moving Average and above the 200-Day Moving Average. The RSI(14) is 63.51. Our indicators give a bullish view on ACT.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ABOUT ACT Actavis plc, an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical products in the United States, Canada, and internationally. It offers generic, branded, branded generic, biosimilar, over-the-counter, biologic, and specialty pharmaceutical products [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":1293,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[111,22],"tags":[362,363,364],"class_list":["post-1292","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stocks-2","category-wall-street","tag-act","tag-actavis-inc","tag-analysis-and-outlook"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Actavis plc (ACT). Analysis and outlook - Futures and Options<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actavis plc (ACT). Analysis and outlook - Futures and Options\" \/>\n<meta property=\"og:description\" content=\"ABOUT ACT Actavis plc, an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical products in the United States, Canada, and internationally. It offers generic, branded, branded generic, biosimilar, over-the-counter, biologic, and specialty pharmaceutical products [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/\" \/>\n<meta property=\"og:site_name\" content=\"Futures and Options\" \/>\n<meta property=\"article:published_time\" content=\"2013-11-28T16:30:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2015-09-11T09:07:00+00:00\" \/>\n<meta name=\"author\" content=\"erevnon.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"erevnon.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/\",\"url\":\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/\",\"name\":\"Actavis plc (ACT). Analysis and outlook - Futures and Options\",\"isPartOf\":{\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-11-28T16:30:56+00:00\",\"dateModified\":\"2015-09-11T09:07:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/#\/schema\/person\/ed8fd77af6fbc77c1cec8fdc9dc9db1f\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.futuresandoptions.gr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actavis plc (ACT). Analysis and outlook\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/#website\",\"url\":\"https:\/\/www.futuresandoptions.gr\/en\/\",\"name\":\"Futures and Options\",\"description\":\"Serving Intelligent Investors\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.futuresandoptions.gr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.futuresandoptions.gr\/en\/#\/schema\/person\/ed8fd77af6fbc77c1cec8fdc9dc9db1f\",\"name\":\"erevnon.com\",\"url\":\"https:\/\/www.futuresandoptions.gr\/en\/author\/erevnon-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actavis plc (ACT). Analysis and outlook - Futures and Options","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/","og_locale":"en_US","og_type":"article","og_title":"Actavis plc (ACT). Analysis and outlook - Futures and Options","og_description":"ABOUT ACT Actavis plc, an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical products in the United States, Canada, and internationally. It offers generic, branded, branded generic, biosimilar, over-the-counter, biologic, and specialty pharmaceutical products [&hellip;]","og_url":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/","og_site_name":"Futures and Options","article_published_time":"2013-11-28T16:30:56+00:00","article_modified_time":"2015-09-11T09:07:00+00:00","author":"erevnon.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"erevnon.com","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/","url":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/","name":"Actavis plc (ACT). Analysis and outlook - Futures and Options","isPartOf":{"@id":"https:\/\/www.futuresandoptions.gr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#primaryimage"},"image":{"@id":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-11-28T16:30:56+00:00","dateModified":"2015-09-11T09:07:00+00:00","author":{"@id":"https:\/\/www.futuresandoptions.gr\/en\/#\/schema\/person\/ed8fd77af6fbc77c1cec8fdc9dc9db1f"},"breadcrumb":{"@id":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/www.futuresandoptions.gr\/en\/actavis-plc-act-analysis-and-outlook\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.futuresandoptions.gr\/en\/"},{"@type":"ListItem","position":2,"name":"Actavis plc (ACT). Analysis and outlook"}]},{"@type":"WebSite","@id":"https:\/\/www.futuresandoptions.gr\/en\/#website","url":"https:\/\/www.futuresandoptions.gr\/en\/","name":"Futures and Options","description":"Serving Intelligent Investors","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.futuresandoptions.gr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.futuresandoptions.gr\/en\/#\/schema\/person\/ed8fd77af6fbc77c1cec8fdc9dc9db1f","name":"erevnon.com","url":"https:\/\/www.futuresandoptions.gr\/en\/author\/erevnon-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/posts\/1292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/comments?post=1292"}],"version-history":[{"count":1,"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/posts\/1292\/revisions"}],"predecessor-version":[{"id":2715,"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/posts\/1292\/revisions\/2715"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/media?parent=1292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/categories?post=1292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.futuresandoptions.gr\/en\/wp-json\/wp\/v2\/tags?post=1292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}